Chronic Bronchitis Life Expectancy

Chronic bronchitis is a progressive condition that develops in the lungs making it very difficult to breathe or perform any physical activity. As the disease worsens, the abilities of the individual suffering from its symptoms are greatly reduced. Simple tasks like walking to the mailbox or taking a shower are difficult and time-consuming at best. As many as 12 million people in America suffer from chronic bronchitis, and the disease is the fourth-leading cause of death according to Healthline.

About Chronic Bronchitis

Chronic bronchitis is one of the major conditions contributing to chronic obstructive pulmonary disease (COPD). Bronchitis is a condition in which the air passages of the lungs become inflamed. The inflammation occurs in the trachea (or windpipe), and in the large and small bronchi (or tree-like air passages in the lungs). Bronchitis is the result of irritation or infection, and can either be short-lived (acute) or re-occurring (chronic). When pulmonary irritation or infection is present, the thin mucous linings that protect the lungs become inflamed. Airway linings start to produce fluid as a result of the inflammation. Coughing is the body’s natural reflex to clear the air passages in the lungs. As a result, sufferers of bronchitis often exhibit a wet, painful cough.

Chronic Bronchitis Life Expectancy

Due to the progressive nature of chronic bronchitis and the fact there is no known cure, a chronic bronchitis diagnosis can make those suffering from the ailment feel hopeless. There are plenty of things one can do to help slow or stop the progression of chronic bronchitis. Exercise, a healthy diet, prescription drugs and stem cell therapy can all be beneficial. Despite all that is known about the disease, there isn’t a current model to predict life expectancy for those who develop it.

Treating Advanced Chronic Bronchitis

Stem cell therapy for lung disease has been increasingly in demand as a treatment option over the past few years. At the Lung Institute, a progressive stem cell treatment clinic that has emerged as a leader in the global stem cell community, stem cells from the patient’s own body are re-purposed to treat lung disease.

In the case of chronic bronchitis, autologous stem cells are used, meaning the cells come from the patient’s own body. They can be found in the patient’s bone marrow and blood (venous tissue). Stem cells derived from venous tissue have the capability to form many types of differentiated cells. During the procedure, adult stem cells are extracted from bone marrow or blood, which requires special laboratory techniques.

After extraction, the stem cells are isolated. Finally, they are returned to the patient intravenously. The treatment is minimally invasive and typically an outpatient procedure. The procedure should be performed in a clinical setting under the supervision of a professional. It takes a physician that has sought specific training to perform stem cell therapy adequately and safely. If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.